These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 15745726)

  • 1. A randomized trial of a primary care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes.
    Rothman RL; Malone R; Bryant B; Shintani AK; Crigler B; Dewalt DA; Dittus RS; Weinberger M; Pignone MP
    Am J Med; 2005 Mar; 118(3):276-84. PubMed ID: 15745726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical clinics versus usual care for patients with both diabetes and hypertension: a randomized trial.
    Edelman D; Fredrickson SK; Melnyk SD; Coffman CJ; Jeffreys AS; Datta S; Jackson GL; Harris AC; Hamilton NS; Stewart H; Stein J; Weinberger M
    Ann Intern Med; 2010 Jun; 152(11):689-96. PubMed ID: 20513826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan.
    Jarab AS; Alqudah SG; Mukattash TL; Shattat G; Al-Qirim T
    J Manag Care Pharm; 2012 Sep; 18(7):516-26. PubMed ID: 22971205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adding pharmacists to primary care teams reduces predicted long-term risk of cardiovascular events in type 2 diabetic patients without established cardiovascular disease: results from a randomized trial.
    Ladhani NN; Majumdar SR; Johnson JA; Tsuyuki RT; Lewanczuk RZ; Spooner R; Simpson SH
    Diabet Med; 2012 Nov; 29(11):1433-9. PubMed ID: 22486226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a Collaborative Care Model on Depressive Symptoms and Glycated Hemoglobin, Blood Pressure, and Serum Cholesterol Among Patients With Depression and Diabetes in India: The INDEPENDENT Randomized Clinical Trial.
    Ali MK; Chwastiak L; Poongothai S; Emmert-Fees KMF; Patel SA; Anjana RM; Sagar R; Shankar R; Sridhar GR; Kosuri M; Sosale AR; Sosale B; Rao D; Tandon N; Narayan KMV; Mohan V;
    JAMA; 2020 Aug; 324(7):651-662. PubMed ID: 32809002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a Pharmacist-Led Program on Improving Outcomes in Patients with Type 2 Diabetes Mellitus from Northern Cyprus: A Randomized Controlled Trial.
    Korcegez EI; Sancar M; Demirkan K
    J Manag Care Spec Pharm; 2017 May; 23(5):573-582. PubMed ID: 28448779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacist-led, primary care-based disease management improves hemoglobin A1c in high-risk patients with diabetes.
    Rothman R; Malone R; Bryant B; Horlen C; Pignone M
    Am J Med Qual; 2003; 18(2):51-8. PubMed ID: 12710553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a Technology-Assisted Integrated Diabetes Care Program on Cardiometabolic Risk Factors Among Patients With Type 2 Diabetes in the Asia-Pacific Region: The JADE Program Randomized Clinical Trial.
    Lim LL; Lau ESH; Fu AWC; Ray S; Hung YJ; Tan ATB; Chamnan P; Sheu WHH; Chawla MS; Chia YC; Chuang LM; Nguyen DC; Sosale A; Saboo BD; Phadke U; Kesavadev J; Goh SY; Gera N; Huyen Vu TT; Ma RCW; Lau V; Luk AOY; Kong APS; Chan JCN;
    JAMA Netw Open; 2021 Apr; 4(4):e217557. PubMed ID: 33929522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacist-led group medical appointments for the management of type 2 diabetes with comorbid depression in older adults.
    Taveira TH; Dooley AG; Cohen LB; Khatana SA; Wu WC
    Ann Pharmacother; 2011 Nov; 45(11):1346-55. PubMed ID: 22028418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of pharmaceutical care on health outcomes in patients with Type 2 diabetes mellitus.
    Al Mazroui NR; Kamal MM; Ghabash NM; Yacout TA; Kole PL; McElnay JC
    Br J Clin Pharmacol; 2009 May; 67(5):547-57. PubMed ID: 19552750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the Effect of Personalized Diabetes Risk Assessments During Ophthalmologic Visits on Glycemic Control: A Randomized Clinical Trial.
    Aiello LP; Ayala AR; Antoszyk AN; Arnold-Bush B; Baker C; Bressler NM; Elman MJ; Glassman AR; Jampol LM; Melia M; Nielsen J; Wolpert HA;
    JAMA Ophthalmol; 2015 Aug; 133(8):888-96. PubMed ID: 25996273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a diabetes specialist-guided primary care diabetes treatment program.
    King AB; Wolfe GS
    J Am Acad Nurse Pract; 2009 Jan; 21(1):24-30. PubMed ID: 19125892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacist-led group medical appointment model in type 2 diabetes.
    Taveira TH; Friedmann PD; Cohen LB; Dooley AG; Khatana SA; Pirraglia PA; Wu WC
    Diabetes Educ; 2010; 36(1):109-17. PubMed ID: 19966072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of diabetes drug counseling by pharmacist, diabetic disease booklet and special medication containers on glycemic control of type 2 diabetes mellitus: a randomized controlled trial.
    Suppapitiporn S; Chindavijak B; Onsanit S
    J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S134-41. PubMed ID: 16623018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Clinical Pharmacist-Led Comprehensive Medication Management on Chronic Disease State Goal Attainment in a Patient-Centered Medical Home.
    Prudencio J; Cutler T; Roberts S; Marin S; Wilson M
    J Manag Care Spec Pharm; 2018 May; 24(5):423-429. PubMed ID: 29694290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study.
    Clifford RM; Davis WA; Batty KT; Davis TM;
    Diabetes Care; 2005 Apr; 28(4):771-6. PubMed ID: 15793171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a Pharmacist-Managed Diabetes Program in a Primary Care Setting Within an Integrated Health Care System.
    Benedict AW; Spence MM; Sie JL; Chin HA; Ngo CD; Salmingo JF; Vidaurreta AT; Rashid N
    J Manag Care Spec Pharm; 2018 Feb; 24(2):114-122. PubMed ID: 29384029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled study to evaluate the effect of pharmacist-led educational intervention on glycemic control, self-care activities and disease knowledge among type 2 diabetes patients: A consort compliant study protocol.
    Bukhsh A; Nawaz MS; Ahmed HS; Khan TM
    Medicine (Baltimore); 2018 Mar; 97(12):e9847. PubMed ID: 29561461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of community pharmacy diabetes monitoring and education programme on diabetes management: a randomized controlled study.
    Ali M; Schifano F; Robinson P; Phillips G; Doherty L; Melnick P; Laming L; Sinclair A; Dhillon S
    Diabet Med; 2012 Sep; 29(9):e326-33. PubMed ID: 22672148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model of care for the management of complex Type 2 diabetes managed in the community by primary care physicians with specialist support: an open controlled trial.
    Russell AW; Baxter KA; Askew DA; Tsai J; Ware RS; Jackson CL
    Diabet Med; 2013 Sep; 30(9):1112-21. PubMed ID: 23758279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.